CATL’s 6.7 per cent discount to its Shenzhen-traded shares is much lower than the average 25 per cent discount for ...

Singapore-based medical testing firm Mirxes joins Jiangsu Hengrui Pharmaceuticals in revitalised market's listing surge ...

Shares of the restaurant chain began trading at HK$7.19 per share, unchanged from the offer price, before plunging 7 per cent ...

Trading in the shares is expected to start on May 23. Read more at straitstimes.com. Read more at straitstimes.com.

SINGAPORE] Companies have been flocking to file applications for initial public offerings (IPOs) in Hong Kong amid ...

SINGAPORE] Singapore biotech start-up Mirxes launched its initial public offering (IPO) in Hong Kong on Thursday (May 15) as ...

This digital payment services provider is likely to get a lift from China's initiatives to boost domestic consumption.

Chinese biotech company Bliss Biopharmaceutical (BlissBio) is reportedly considering a Hong Kong initial public offering (IPO ...

This week, CATL, a leading domestic lithium battery company, launched its Hong Kong IPO, heating up the lithium battery sector.

Pfizer and RemeGen's HER2 antibody-drug conjugate delivered positive phase 3 results in a bladder cancer trial in China. | ...

Now, with tensions easing and the US$43.6 billion ($56.62 billion) raised in 2025 IPOs so far running just behind the same ...

SYDNEY: Chinese battery giant CATL has raised $4.6 billion in its Hong Kong listing, the largest listing globally so far for ...